We are live on
!
Find out more
Zurich Cantonal Bank Portfolio holdings
AUM
$46B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$30.7B
AUM Growth
+$2.2B
(+7.7%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
4.07%
Top 10 Holdings %
Top 10 Hldgs %
34.82%
Holding
2,753
New
46
Increased
1,356
Reduced
554
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$164M |
| 2 |
Microsoft
MSFT
|
+$96.1M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$95.4M |
| 4 |
Amazon
AMZN
|
+$84.3M |
| 5 |
Apple
AAPL
|
+$79.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$49.8M |
| 2 |
Texas Instruments
TXN
|
+$45.8M |
| 3 |
Adobe
ADBE
|
+$45.1M |
| 4 |
Chevron
CVX
|
+$42.9M |
| 5 |
Keysight
KEYS
|
+$32.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.54% |
| 2 | Financials | 15.58% |
| 3 | Healthcare | 13.56% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Mesa Laboratories
MLAB
$574M
| $12.8K | ﹤0.01% |
148
| – | – |
|
2552
Global Water Resources
GWRS
$219M
| $12.4K | ﹤0.01% |
+1,025
| New | +$12.8K |
|
|
WBX
2553
Wallbox
WBX
$81.5M
| $12.2K | ﹤0.01% |
474
| – | – |
|
2554
Anavex Life Sciences
AVXL
$310M
| $12.2K | ﹤0.01% |
2,882
-25,663
| -90% | -$104K |
|
2555
AstraZeneca
AZN
$250B
| $11.7K | ﹤0.01% |
75
| – | – |
|
2556
Cricut
CRCT
$1.22B
| $11.6K | ﹤0.01% |
1,932
| – | – |
|
|
ALLK
2557
DELISTED
Allakos
ALLK
| $11.4K | ﹤0.01% |
11,388
-2,377
| -17% | -$2.82K |
|
|
GRFS
2558
Grifois
GRFS
$5.4B
| $10.1K | ﹤0.01% |
1,609
-24
| -1% | -$167 |
|
2559
MeiraGTx Holdings
MGTX
$1.21B
| $10.1K | ﹤0.01% |
2,393
-69
| -3% | -$348 |
|
|
CTEV
2560
Claritev Corp
CTEV
$556M
| $9.7K | ﹤0.01% |
624
| – | – |
|
2561
Zegna
ZGN
$4B
| $9.25K | ﹤0.01% |
+781
| New | +$9.6K |
|
|
AUTL
2562
Autolus Therapeutics
AUTL
$562M
| $8.92K | ﹤0.01% |
2,564
-69
| -3% | -$298 |
|
2563
Vitamin Cottage Natural Grocers
NGVC
$654M
| $8.61K | ﹤0.01% |
406
-3,923
| -91% | -$74.7K |
|
2564
BioXcel Therapeutics
BTAI
$27.8M
| $8.42K | ﹤0.01% |
411
-67
| -14% | -$2.24K |
|
2565
Immunocore
IMCR
$1.73B
| $8.4K | ﹤0.01% |
248
-6
| -2% | -$306 |
|
2566
Consolidated Water Co
CWCO
$488M
| $8.2K | ﹤0.01% |
309
+298
| +2,709% | +$7.8K |
|
2567
Artesian Resources
ARTNA
$358M
| $5.87K | ﹤0.01% |
167
-1,928
| -92% | -$69.8K |
|
2568
Personalis
PSNL
$1.51B
| $5.08K | ﹤0.01% |
4,344
-679
| -14% | -$932 |
|
2569
GoPro
GPRO
$126M
| $3.02K | ﹤0.01% |
2,127
-16,479
| -89% | -$27.5K |
|
|
SGMO
2570
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3.01K | ﹤0.01% |
8,392
-1,440
| -15% | -$778 |
|
2571
Precision BioSciences
DTIL
$207M
| $2.75K | ﹤0.01% |
283
-70
| -20% | -$825 |
|
|
RAPT
2572
DELISTED
RAPT Therapeutics
RAPT
| $2.21K | ﹤0.01% |
91
-492
| -84% | -$22.7K |
|
|
MRNS
2573
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.97K | ﹤0.01% |
1,683
-71
| -4% | -$178 |
|
2574
Inhibrx
INBX
$1.3B
| $1.67K | ﹤0.01% |
+118
| New | +$1.84K |
|
2575
American Public Education
APEI
$940M
| $1.58K | ﹤0.01% |
+90
| New | +$1.41K |
|
Similar funds
LP
TI
Zurich Cantonal Bank's Q2 2024 Portfolio in Review
As of Q2 2024, Zurich Cantonal Bank held 2,753 positions worth $30.7B, up 7.7% from $28.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Zurich Cantonal Bank deployed $1.25B of net new capital in Q2 2024, opening 46 new positions and adding to 1,356 existing holdings. Its largest new stake was GE Vernova: 126,606 shares worth $21.7M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $49.8M trimmed.
- Zurich Cantonal Bank's largest Q2 2024 buy was GE Vernova: 126,606 shares worth $21.7M.
- Zurich Cantonal Bank added most to UBS Group in Q2 2024, an estimated $164M increase.
- Zurich Cantonal Bank's biggest Q2 2024 reduction was Merck, cutting an estimated $49.8M.
- Zurich Cantonal Bank fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $21.3M.
- Zurich Cantonal Bank's ten largest holdings make up 35% of its $30.7B portfolio in Q2 2024.
- Zurich Cantonal Bank opened 46 new positions and closed 109 in Q2 2024.
- Zurich Cantonal Bank's portfolio value rose 7.7% quarter-over-quarter to $30.7B.
Based on Zurich Cantonal Bank's 13F filing for Q2 2024, filed 29 Jul 2024.